Sort
17,288 grants matching “multiple sclerosis”
REGENERATIVE NANOTECHNOLOGY TO PROMOTE REGULATORY T CELL-MEDIATED OLIGODENDROGENESIS AND REMYELINATION IN MULTIPLE SCLEROSIS
$237,808The Johns Hopkins University · · FY2021 · Defense Health Agency
Cytokine Regulation of Normal and Neoplastic Hematopoietic Cell Growth
$237,786Francis W. Ruscetti · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Generation and characterization of a novel cell subpopulation ablation model
$237,750Xuebin Qin · Temple Univ Of The Commonwealth · R21 · FY2018 · OD
In vivo production of a potassium channel inhibitor for immunomodulation
$237,750Christine Beeton · Baylor College Of Medicine · R21 · FY2019 · AI
Novel Ultrashort Echo Time Sequences for Brain MRI
$237,750Peder Eric Zufall Larson · University Of California, San Francisco · R21 · FY2017 · NS
Validation of CD6 as a New Target for Treating Multiple Sclerosis
$237,750Feng Lin · Cleveland Clinic Lerner Com-Cwru · R21 · FY2013 · NS
Potential of tissue kallikreins as therapeutic targets for neuropsychiatric lupus
$237,750Uma Sriram · Temple Univ Of The Commonwealth · R21 · FY2023 · AI
OLFACTION IN MULTIPLE SCLEROSIS
$237,635University Of Pennsylvania · R01 · FY2001 · DC
Identification of a novel pathway that regulates optic nerve myelination and remyelination
$237,621Lu Sun · Ut Southwestern Medical Center · R00 · FY2022 · EY
Project 3
$237,615David R Borchelt · University Of California Los Angeles · P01 · FY2014 · NS
UCSF-Stanford Center of Excellence in Regulatory Science and Innovation
$237,563Kathleen M Giacomini · University Of California, San Francisco · U01 · FY2015 · FD
GENDER INFLUENCES IMMUNOREGULATION IN R EAE
$237,512Oregon Health And Science University · R01 · FY2001 · AI
A novel role of hypusination in controlling regulatory T cell function
$237,500Ye Zheng · Salk Institute For Biological Studies · R21 · FY2022 · AI
Define the role of REV-ERB in colonic RORgt+ regulatory T cells
$237,500Ye Zheng · Salk Institute For Biological Studies · R21 · FY2024 · AI
Defining Epstein-Barr virus reservoirs and EBV-regulated gene expression in multiple sclerosis
$237,476Micah A. Luftig · Duke University · R21 · FY2025 · NS
Neuroprotective mechanisms of CXCL12 in CNS demyelinating diseases
$237,444Robyn S Klein · Washington University · P01 · FY2011 · NS
Directional Diffusivity as a Window into the Pathology of Multiple Sclerosis (MS)
$237,409Dorothy Anne Cross · Washington University · P01 · FY2010 · NS
Mechanistic studies of novel factors regulating axon regeneration in the PNS/CNS
$237,381Yuanquan Song · Children'S Hosp Of Philadelphia · R00 · FY2018 · NS
Research Training in Rehabilitation for Brain Injury and Neurological Disability
$237,376Michael Van Doren Johnston · Hugo W. Moser Res Inst Kennedy Krieger · T32 · FY2011 · HD
Tissue Specific Control of Cholesterol Metabolism
$237,330Ira G Schulman · University Of Virginia · R21 · FY2022 · AG
Astrocyte regulation of CNS remyelination
$237,300Gareth R John · Icahn School Of Medicine At Mount Sinai · R01 · FY2008 · NS
Astrocyte regulation of CNS remyelination
$237,300Gareth R John · Icahn School Of Medicine At Mount Sinai · R01 · FY2009 · NS
Astrocyte regulation of CNS remyelination
$237,300Gareth R John · Icahn School Of Medicine At Mount Sinai · R01 · FY2009 · NS
NEURAL MECHANISMS UNDERLYING MODULATORY CONTROL OF PAIN IN MULTIPLE SCLEROSIS
$237,235Icahn School Of Medicine At Mount Sinai · · FY2017 · Department of the Army
Synergy between T cells and Complement in EAE
$237,137Feng Lin · Case Western Reserve University · R01 · FY2007 · NS